Liquid pharmaceutical formulations of PTH conjugates

A liquid pharmaceutical formulation, wherein the pharmaceutical formulation comprises a PTH conjugate of formula

• or a pharmaceutically acceptable salt thereof,
• wherein
• the unmarked dashed line indicates attachment by an amide bond to an N-terminal amine of a PTH moiety, which is PTH1-34 (SEQ ID NO:51);
• and
• the dashed line marked with the asterisk indicates attachment to a moiety
• wherein m and p are independently an integer from 400-500,
• succinic acid, D-mannitol and m-cresol, wherein the PTH moiety is at about 0.3 mg/ml mg/ml, the succinic acid is at about 1.18 mg/ml, the D-mannitol is at about 41.7 mg/ml, and the m-cresol is at about 2.5 mg/ml and wherein the pH is about 4.0, wherein about indicates variation of +/−10% of a stated value.